| Active principles | Rating | Bibliogr. | Expand | |
|---|---|---|---|---|
| 1 | HLA-B27 Antigen | 100 | + | |
| 2 | Receptors, Tumor Necrosis Factor | 72 | + | |
| 3 | Tumor Necrosis Factor-alpha | 56 | + | |
| 4 | Immunoglobulin G | 44 | + | |
| 5 | Antibodies, Monoclonal | 43 | + | |
| 6 | Sulfasalazine | 41 | + | |
| 7 | C-Reactive Protein | 22 | + | |
| 8 | Antibodies, Monoclonal, Humanized | 19 | + | |
| 9 | Phenylbutazone | 18 | + | |
| 10 | Naproxen | 18 | + | |
| 11 | Matrix Metalloproteinase 3 | 17 | + | |
| 12 | Apazone | 13 | + | |
| 13 | Biological Products | 11 | + | |
| 14 | Radium | 11 | + | |
| 15 | Wnt3A Protein | 10 | + | |
| 16 | Methotrexate | 9 | + | |
| 17 | Homogentisic Acid | 9 | + | |
| 18 | Thorium | 8 | + | |
| 19 | Secretory Component | 8 | + | |
| 20 | Piroxicam | 8 | + | |
| 21 | Samarium | 7 | + | |
| 22 | Intercellular Signaling Peptides and Proteins | 7 | + | |
| 23 | Osteoprotegerin | 7 | + | |
| 24 | Ataxia Telangiectasia Mutated Proteins | 7 | + | |
| 25 | Acute-Phase Proteins | 6 | + | |
| 26 | Recombinant Fusion Proteins | 5 | + | |
| 27 | Diclofenac | 5 | + | |
| 28 | Thalidomide | 5 | + | |
| 29 | Diphosphonates | 4 | + | |
| 30 | Isoxazoles | 4 | + | |
| 31 | Immunoglobulin A | 4 | + | |
| 32 | Sulfones | 4 | + | |
| 33 | RANK Ligand | 4 | + | |
| 34 | Interleukin-6 | 4 | + | |
| 35 | Pyridines | 3 | + | |
| 36 | Cytokines | 2 | + |